A sharpshooter for bacteria is in development to combat infections in the Intensive Care Unit. BiosparQ, a diagnostics company based in Leiden, thinks it can make an important contribution to the treatment of coronavirus COVID-19 patients in the Intensive Care Unit, but is urgently looking for partners. It concerns the analysis and combat of co-infections…

At the ICU, time is of essence to optimize antibiotics prescription for bacterial co-infections of COVID-19 patients and BiosparQ can realize a POCT device that enables informed treatment decisions within 30 minutes Leiden – Coronavirus has taken the world by unprecedented force, with patients at the ICU fighting to stay alive. However, many of these…